
Drugs Associated With the Development of Palmoplantar Keratoderma: A Systematic Review
Author(s) -
Sara Mirali,
Abrahim Abduelmula,
Asfandyar Mufti,
Muskaan Sachdeva,
Jensen Yeung
Publication year - 2021
Publication title -
journal of cutaneous medicine and surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.593
H-Index - 47
eISSN - 1615-7109
pISSN - 1203-4754
DOI - 10.1177/12034754211004560
Subject(s) - medicine , adverse effect , palmoplantar keratoderma , dermatology , keratoderma , hyperkeratosis
Palmoplantar keratoderma (PPK) are a heterogenous group of hereditary and acquired disorders that are characterized by excessive epidermal thickening of the palms and/or soles. PPK has been described as a rare adverse event for some medications. The aim of this systematic review was to summarize outcomes in PPK associated with various medications. This data will assist dermatologists and other healthcare providers treating patients with drug-induced PPK.